Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bliss Kaneshiro, MD, MPH
Queen's Medical Center
Principal Investigator - Corrie Miller, DO
University of Hawaii
Principal Investigator - Olivia Manayan, MD, MPH
University of Hawaii
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queens Medical Center, 1004 Clinic Pob1
Honolulu, Hawaii, United States
Olivia H Manayan, MD MPHRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2023
- Primary completion
- 30 Oct 2026
- Completion
- 30 Dec 2026
- Last update posted
- 20 Feb 2026
- Registered enrollment
- 22
- Registry id
- NCT05753813
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.